ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 650025 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 650025; 2) Community: the network communities that were significantly associated with the response to NSC 650025; 3) Molecule: the relationships between components within communities and NSC 650025; 4) MDR: the compounds that were significantly associated with the NSC 650025.

NSC Compound Enrichment Correlation
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 0.00347157511980532 0.32927275
NSC 670312 Null 0.00397405528023196 0.47354467
NSC 679108 Phenol, 4,4'-(5,5'-biisoxazole-3,3'-diyl)bis- 0.00397405528023196 0.53437539
NSC 681152 Benzoic acid, 4-[2-(2,5-dihydroxyphenyl)ethyl]-, methyl ester 0.00397405528023196 0.56910516
NSC 681642 Camptothecin Derivative 0.00397405528023196 0.37905509
NSC 699956 Null 0.00397405528023196 0.40699827
NSC 740963 Null 0.00397405528023196 0.50525294
NSC 633275 3-Azabicyclo(3.2.2)nonan-3-ylcarbothioic acid, 1-(4-pyrimidinyl)ethylidene)hydrazide, copper complex 0.00397405528023199 0.45934012
NSC 636087 Null 0.00397405528023199 0.34386282
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.00433056621075587 0.2447933
Total:79  Current:7    [First] [Prev] [Next] [Last]